AAVantgarde presents positive preclinical data in large animal models from its Stargardt ...
MILAN, Italy, April 23, 2024 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today
United States Aavantgarde Bio Natalia Misciattelli Alberto Auricchio Magda Blanco Telethon Institute Of Genetics
Source: bdtonline.com